Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lobe Sciences Ltd Ordinary Shares GTSIF

Healthcare Drug Manufacturers - Specialty & Generic
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

Bullboard (OTCPK:GTSIF)

View:
Prev 1 2 3 4 5 Next
Comment by Marcinon Jun 17, 2022 2:00pm

RE:RE:RE:RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

BIG BIDS COMING IN (myself included) -- Marcin Ashley VanDyke wrote Well said !! GajjarDr wrote What is most intersting is L-130 drug. As stated in NR... "Lobe will investigate the safety and ...more  
138
Discussion
Comment by ashleyvandykeon Jun 16, 2022 2:15pm

RE:RE:RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

Well said !! GajjarDr wrote What is most intersting is L-130 drug. As stated in NR... "Lobe will investigate the safety and tolerability of an oral drug candidate, L-130 (a molecular modification ...more  
147
Discussion
Comment by GajjarDron Jun 16, 2022 1:50pm

RE:RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

What is most intersting is L-130 drug. As stated in NR... "Lobe will investigate the safety and tolerability of an oral drug candidate, L-130 (a molecular modification of naturally occurring ...more  
162
Discussion
Comment by BellaLacksDaddyon Jun 16, 2022 12:54pm

RE:RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

What was the stock price before the recent share split? The Companies twitter page only has 1000 followers; a media endeavor would be a great idea for company to get more public attention.
147
Discussion
Comment by fTrudeauon Jun 15, 2022 4:46pm

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

i read the news release. Doesn't mention much about 2023 but this company definitely has major potential... I wonder how FDA meeting will be in 3rd Q of 2022. They did a share split recently which ...more  
114
Discussion
Comment by fTrudeauon Jun 15, 2022 4:45pm

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

i read the news release. Doesn't mention much about 2023 but this company definitely has major potential... I wonder how FDA meeting will be in 3rd Q of 2022. They did a share split recently which ...more  
118
Discussion
Comment by fTrudeauon Jun 15, 2022 4:43pm

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

i read the news release. Doesn't mention much about 2023 but this company definitely has major potential... I wonder how FDA meeting will be in 3rd Q of 2022. They did a share split recently which ...more  
110
Discussion
Comment by CryptoChickon Jun 15, 2022 4:35pm

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

What a great cheap mushroom play!!  Thanks for the info  
120
Discussion
Post by initforthemushon Jun 15, 2022 3:23pm

NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

Newsfile Corp. - June 14, 2022) - Lobe Sciences Ltd. (CSE: LOBE) Lobe is preparing a pre-IND meeting request with the US Food and Drug Administration (FDA) to confirm its regulatory strategy ...more  
532
Discussion
Post by Betteryear2on Dec 21, 2021 8:53am

Publication of PCT Patent Application

"Methods, Compositions and Devices for Treating Mild Traumatic Brain Injury, Post Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic Stress Disorder" Vancouver ...more  
172
Comment by yvreanon Dec 08, 2021 11:00pm

RE:Lobe will have some money soon...

It's more ownership percentage than anything. Lobe can't own more than 9% as they would have controlling interest and they don't wantr that. So they are dumping free shares that IONIC ...more  
233
Discussion
Prev 1 2 3 4 5 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities